UnitedHealth Group's i3 announces "Phase I" Business Expansion In Japan
This article was originally published in PharmAsia News
Executive Summary
TOKYO - After two years of plotting an entry into the Japanese healthcare market, i3 Japan LLC, a fully owned subsidiary of UnitedHealth Group, announced July 1 it would start offering its services actively in the clinical development and National Health Insurance areas as part of a "Phase I business expansion"